ASX Filings

Appendix 3B

November 30, 2018

Opthea CEO Presentation to the 2018 AGM

November 29, 2018

Opthea Chairman Address to the 2018 AGM

November 29, 2018

Results of Meeting

November 29, 2018

Opthea Options Exercise Generates Proceeds of A$13.3m

November 28, 2018

Appendix 3B

November 28, 2018

Opthea confirms final patient enrolment in Ph2b wAMD trial

November 26, 2018

Appendix 3B

November 21, 2018

Appendix 3B

November 16, 2018

Change in substantial holding

November 15, 2018